UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment

Seminars in cancer biology, 2018-10, Vol.52 (Pt 2), p.259-268

2018

Volltextzugriff (PDF)

Abstract P2-02-16: Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-02-16

2018

Volltextzugriff (PDF)

Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2800-2807

2004

Volltextzugriff (PDF)

Pemetrexed-associated urticarial vasculitis

Lung cancer (Amsterdam, Netherlands), 2006-02, Vol.51 (2), p.247-249

2006

Volltextzugriff (PDF)

New developments in chemotherapy for advanced non-small cell lung cancer

Current opinion in internal medicine, 2006-03, Vol.18 (2), p.156-161

2006

Volltextzugriff (PDF)

Therapeutic vaccines in non-small cell lung cancer

ImmunoTargets and therapy, 2013-01, Vol.2 (Issue 1), p.115-124

2013

Volltextzugriff (PDF)

Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4244-4245

2005

Volltextzugriff (PDF)

Emerging role of multikinase inhibitors for refractory thyroid cancer

Biologics, 2012-01, Vol.6 (default), p.257-265

Perez, Cesar A

2012

Volltextzugriff (PDF)

The utility of a bone marrow biopsy in diagnosing the source of fever of unknown origin in patients with AIDS

Journal of acquired immune deficiency syndromes (1999), 2004-12, Vol.37 (5), p.1599-1603

2004

Volltextzugriff (PDF)

Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer—experience from a prematurely closed phase II study

Lung cancer (Amsterdam, Netherlands), 2004-07, Vol.45 (1), p.131-132

2004

Volltextzugriff (PDF)

DNA methylation: its role in lung carcinogenesis and therapeutic implications

Expert review of anticancer therapy, 2005-08, Vol.5 (4), p.667-679

2005

Volltextzugriff (PDF)

Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines

Expert review of anticancer therapy, 2005-08, Vol.5 (4), p.635-644

2005

Volltextzugriff (PDF)

Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma

Cancer gene therapy, 2003-11, Vol.10 (11), p.850-858

2003

Volltextzugriff (PDF)

Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia

Leukemia & lymphoma, 2005-02, Vol.46 (2), p.297-298

2005

Volltextzugriff (PDF)

Pulmonary bone marrow embolism in sickle cell disease

Southern medical journal (Birmingham, Ala.), 1999-02, Vol.92 (2), p.245-247

1999

Volltextzugriff (PDF)

Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL)

Critical reviews in oncogenesis, 1998, Vol.9 (3-4), p.199

1998

Volltextzugriff (PDF)

Successful treatment of lymphomatoid granulomatosis using cyclosporin‐A after failure of intensive chemotherapy

American journal of hematology, 1996-11, Vol.53 (3), p.192-195

1996

Volltextzugriff (PDF)

Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?

Critical reviews in oncogenesis, 1998, Vol.9 (3-4), p.269

1998

Volltextzugriff (PDF)

Post-liver transplantation lymphoproliferative disorders with and without infusions of donor bone marrow cells

Critical reviews in oncogenesis, 1999, Vol.10 (3), p.239

1999

Volltextzugriff (PDF)

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers

The oncologist (Dayton, Ohio), 2022-05, Vol.29 (6), p.e779-e788

2022

Volltextzugriff (PDF)

222O Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours

Annals of oncology, 2022-11, Vol.33, p.S1521-S1522

2022

Volltextzugriff (PDF)

667P Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours

Annals of oncology, 2022-09, Vol.33, p.S847-S848

2022

Volltextzugriff (PDF)

Shed Membrane Vesicles and Selective Localization of Gelatinases and MMP-9/TIMP-1 Complexes

Annals of the New York Academy of Sciences, 1999-06, Vol.878 (1), p.497-499

1999

Volltextzugriff (PDF)

Phase II two-arm study of tepotinib plus osimertinib in patients with EGFR -mutant NSCLC and acquired resistance to first-line osimertinib due to MET amplification: INSIGHT 2

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS9136-TPS9136

2021

Volltextzugriff (PDF)

Ensayo de una Bibliografía Castillista

FENIX, 2021-01 (10), p.157-187

Raez Patiño, Sara

2021

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Humans
(21)
Life Sciences & Biomedicine
(21)
Oncology
(16)
Medicine, General & Internal
(15)
Health Care Sciences & Services
(14)
Medicine, Research & Experimental
(14)
Medical Ethics
(13)
Medical Laboratory Technology
(13)
Health Policy & Services
(12)
Medicine, Legal
(11)
Female
(10)
Male
(10)
Ophthalmology
(9)
Public, Environmental & Occupational Health
(9)
Aged
(8)
Integrative & Complementary Medicine
(8)
Middle Aged
(8)
Adult
(7)
Biological And Medical Sciences
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment

Abstract P2-02-16: Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients

Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer

Pemetrexed-associated urticarial vasculitis

New developments in chemotherapy for advanced non-small cell lung cancer

Therapeutic vaccines in non-small cell lung cancer

Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer

Emerging role of multikinase inhibitors for refractory thyroid cancer

The utility of a bone marrow biopsy in diagnosing the source of fever of unknown origin in patients with AIDS

Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer—experience from a prematurely closed phase II study

DNA methylation: its role in lung carcinogenesis and therapeutic implications

Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines

Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma

Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia

Pulmonary bone marrow embolism in sickle cell disease

Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL)

Successful treatment of lymphomatoid granulomatosis using cyclosporin‐A after failure of intensive chemotherapy

Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?

Post-liver transplantation lymphoproliferative disorders with and without infusions of donor bone marrow cells

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers

222O Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours

667P Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours

Shed Membrane Vesicles and Selective Localization of Gelatinases and MMP-9/TIMP-1 Complexes

Phase II two-arm study of tepotinib plus osimertinib in patients with EGFR -mutant NSCLC and acquired resistance to first-line osimertinib due to MET amplification: INSIGHT 2

Ensayo de una Bibliografía Castillista

Aktive Filter

Suchergebnisse filtern